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Human liver fluke infection caused by
Clonorchis sinensis, Opisthorchis viverrini, and
O. felineus remains a major public health
problem, affecting the poor in the poorest
regions of Asia. An estimated 45 million
people are infected and more than 600
million are at risk of these infections [1,2].
This Viewpoint highlights the distribution
of the infection, clinical features, neglect of
liver fluke infection, and how the global
health community can help to eradicate
the infection in Asia.
Distribution of the Infection
Most of those infected with liver fluke
live in Asia. C. sinensis is endemic in south
China, northern Vietnam, Taiwan, and
Korea, while O. viverrini is found mainly in
Thailand, Lao People’s Democratic Re-
public (PDR), Cambodia, and central
Vietnam. In Northeast Thailand and
Laos, despite widespread administration
of the anthelmintic drug praziquantel, the
prevalence of O. viverrini approaches 85%
in endemic areas in Lao PDR [3]. A
recent survey in the Chi River basin in
northeast Thailand found a prevalence of
O. viverrini of up to 78% in certain villages
(B. Sripa, T. Laha, J. Bethony, P. J.
Brindley, et al., unpublished data). An
estimated 6 million people in Thailand are
infected with Opisthorchis [4].
Clinical Features
Liver fluke infections are associated with
several hepatobiliary diseases, including
cholangitis, cholecystitis, gallstones, hepa-
tomegaly, and cholangiocarcinoma
(CCA), the primary liver cancer that arises
from biliary epithelial cells [5]. Opisthorchis
is one of two helminth parasites (O. viverrini
and Schistosoma hematobium) that are carci-
nogenic to humans, as reported by the
World Health Organization and the
International Agency for Research on
Cancer [6]. In Thailand, CCA is the most
prevalent of the fatal neoplasias, and liver
and bile duct cancer ranks at number five
in the list of diseases in Thailand that
cause the highest number of disability
adjusted life years (DALYs) [7]. CCA is
responsible for about 15%–25% of liver
cancers in the United States but represents
86.5% of all cancers in Thailand’s Khon
Kaen region, the highest incidence in the
world (Figure 1) [5].
The Neglect of Liver Fluke
Infections
Despite the high prevalence of liver
flukes in Asia, and the associated hepato-
biliary disease, these infections are rela-
tively neglected, not only by national
governments but also by international
health organizations and granting agen-
cies. Because of the rapid economic
growth during the past decade in Asia,
an epidemiological transition has oc-
curred—there has been an increase in
‘‘Western’’ life styles (such as adopting
Western diets) and a rise in the so-called
chronic diseases of affluence, particularly
in the middle class population. For
example, in Thailand, the top four causes
of death in the year 2004 were heart
disease, diabetes, hypertension, and cancer
[7]. The Thailand National Health Stra-
tegic Plan 10 (2007–2011) therefore main-
ly focuses on these diseases and emerging
infections, i.e. avian influenza, HIV/
AIDS, influenza, and tuberculosis (TB)
[8]. Other infectious diseases with high
morbidity/mortality such as malaria, den-
gue, leptospirosis, filariasis, and leprosy are
always on the list of priorities of the
Ministry of Public Health [9]. However,
asymptomatic parasitic infections, includ-
ing those caused by liver fluke, that affect
the poor and poorest people (i.e., the
majority of the population) have received
less attention. A major Thai campaign to
eliminate liver fluke that was operational a
decade ago has now disappeared, even
though the infection is still endemic in
northeastern and northern parts of Thai-
land [4]. Similar situations have been
described in other liver fluke endemic
countries of Asia [10].
At the regional and global level, liver
flukes are also neglected. For example,
they are not listed in the current disease
portfolio of the Special Programme for
Research and Training in Tropical Dis-
eases [11]. The WHO Control of Neglect-
ed Tropical Diseases (NTDs) project
currently lists 14 targeted tropical diseases
(Box 1), but liver flukes are excluded [12].
Moreover, liver flukes are not included in
the WHO’s strategic plan, Global Plan to
Combat Neglected Tropical Diseases 2008–2015
[13]. In Asia, the WHO Regional Offices
for Southeast Asia (SEARO) and the
Western Pacific (WPRO) focus on major
communicable diseases in the region such
as HIV/AIDS, TB, influenza, malaria,
and dengue [10,14]. SEARO clearly
stated plans to eradicate and eliminate
four neglected tropical diseases, including
leprosy, lymphatic filariasis, kala-azar, and
yaw in the strategic plan for 2008–2009,
but not liver flukes [14].
Because of the neglect by health policy-
makers at national, regional, and global
levels, liver flukes are not recognized as
targeted diseases for grant funding. During
the past few years, there has been
increased interest shown by several agen-
cies in supporting the control of neglected
tropical diseases. For example, in 2006,
the United States Agency for International
Development (USAID) awarded RTI In-
ternational $100 million for a neglected
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goal of delivering integrated treatments to
40 million people in Africa over 5 years
[15]. The Bill & Melinda Gates Foundation
has launched global health research grants
with a total budget of $46.7 million to fight
against NTDs [16]. However, these two
major granting agencies appear only focus
on those NTDs that are listed by WHO
[12]. Meanwhile, important national re-
search in poor Asian countries that is
crucial to the control of liver fluke infection
remains sidelined by granting agencies.
Thosesufferingfromliverflukeinfection,
and those working to eradicate it, have very
little voice. In an effort to remedy this
situation, researchers drawn from Asian
countries where liver fluke is endemic,
including Thailand, Lao PDR, Vietnam,
Cambodia, China, and Korea, agreed to
set up the Liver Fluke Network. The formal
establishment of this network took place on
5–10 September 2007 at the 7th Regional
Network on Asian Schistosomiasis and
Other Helminth Zoonoses (RNAS
+) Work-
shop and the First International Sympo-
sium on Geospatial Health held in Lijiang,
Yunnan Province, People’s Republic of
China. The network’s shared concern,
which brings us together, is that the liver
fluke infections are neglected diseases in the
official list of neglected tropical diseases.
The aim of the network is to exchange
expertise, collaborate, and cooperate in
liver fluke research to fight against these
infections in Asia (the specific aims are
shown in Box 2). The network is promoting
research not only on the epidemiology of
the disease, but also on basic science studies
Figure 1. Incidence of CCA and O. viverrini in Thailand from 1990 to 2001. (A) Increasing intensity of red represents increasing prevalence of
O. viverrini, while increasing number of dots represents increasing cancer rates. In general, higher O. viverrini prevalence correlates with a higher CCA
burden, although sporadic anthelmintic therapy has influenced this relationship. It should be noted that even one spot represents significant cancer
rates anywhere else in the world. *Truncated age-standardized incidence from 35 to 64 years. **Age-standardized incidence of CCA throughout
registered regions [6]. (B–E) Cyrinoid fishes that represent the intermediate host of the O. viverrini parasite (B); a dish of koi-pla (minced fish and
condiments), which is thought to represent a common source of infectious metaceraciae of O. viverrini (C); photomicrograph of an adult O. viverrini
worm in bile ducts of experimentally infected hamster (D); photograph of cholangiocarcinoma in human liver from a patient from Khon Kaen,
Thailand (E). (Modified from Sripa et al. [5].)
doi:10.1371/journal.pntd.0000232.g001
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on liver fluke biology, molecular biology,
pathobiology, immunology, diagnosis, and
vector biology. Details of our proposed
strategic plan and activities can be viewed
at http://www.liverfluke.net/.
However, the Liver Fluke Network has
only just started and we have no definite
funding support. We therefore seek collab-
oration and affiliation with health organiza-
tions, institutions, and foundations to move
our plan forward. Because of our budget
constraints, we plan to have the first meeting
at the 17th International Congress for
Tropical Medicine and Malaria in Jeju
Island, Korea, on September 29–October
3, 2008 (http://www.ictm17.org/), where
we will organize a symposium on liver fluke
diseases. We, researchers from endemic
regions, hope that the global health com-
munity, especially health organizations,
governmental and private foundations, and
granting agencies, will consider supporting
our activities. It is time to put liver fluke
infection firmly on the global health agenda.
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Box 1. The 14 Target Diseases of the WHO’s Control of
Neglected Tropical Diseases Department (from [12])
N Buruli ulcer
N Chagas disease
N Cholera/epidemic diarrhoeal diseases
N Dengue/dengue haemorrhagic fever
N Dracunculiasis (guinea worm)
N Endemic treponematoses (yaws, pinta, endemic syphilis)
N Human African trypanosomiasis (sleeping sickness)
N Leishmaniasis
N Leprosy
N Lymphatic filariasis
N Onchocerciasis
N Schistosomiasis
N Soil-transmitted helminthiasis
N Trachoma
Box 2. The Specific Aims of the Liver Fluke Network
(www.liverfluke.net/)
1. To promote interaction between scientists who are working in liver fluke
research in Asia.
2. To facilitate research capacity building and technical support to Liver Fluke
Network members through dissemination of information on training opportu-
nities in relation to research on the control of the liver flukes.
3. To identify and disseminate information on funding opportunities for liver fluke
research.
4. To share plans for new liver fluke research areas and exploring potential projects
for international collaboration.
5. To facilitate the translation of basic research findings into practical applications,
particularly those relevant to the prevention and control of liver fluke infections
and related hepatobiliary diseases.
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